Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1973 1
1982 2
1994 1
1995 1
1996 2
1997 1
1998 1
2000 5
2001 9
2002 3
2003 1
2004 1
2005 6
2006 3
2007 2
2008 1
2009 1
2010 1
2011 4
2012 1
2013 1
2014 2
2015 7
2016 2
2017 5
2018 3
2019 7
2020 10
2021 12
2022 14
2023 14
2024 14
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Engrailed and tectum development.
Omi M, Nakamura H. Omi M, et al. Dev Growth Differ. 2015 Feb;57(2):135-45. doi: 10.1111/dgd.12197. Epub 2015 Feb 25. Dev Growth Differ. 2015. PMID: 25716935 Review.
In Ovo Electroporation Methods in Chick Embryos.
Harada H, Omi M, Nakamura H. Harada H, et al. Among authors: omi m. Methods Mol Biol. 2017;1650:167-176. doi: 10.1007/978-1-4939-7216-6_10. Methods Mol Biol. 2017. PMID: 28809020
Mucolytic bacteria license pathobionts to acquire host-derived nutrients during dietary nutrient restriction.
Sugihara K, Kitamoto S, Saraithong P, Nagao-Kitamoto H, Hoostal M, McCarthy C, Rosevelt A, Muraleedharan CK, Gillilland MG 3rd, Imai J, Omi M, Bishu S, Kao JY, Alteri CJ, Barnich N, Schmidt TM, Nusrat A, Inohara N, Golob JL, Kamada N. Sugihara K, et al. Among authors: omi m. Cell Rep. 2022 Jul 19;40(3):111093. doi: 10.1016/j.celrep.2022.111093. Cell Rep. 2022. PMID: 35858565 Free PMC article.
The efficacy and safety of lenvatinib plus pembrolizumab in vulnerable patients with metastatic or recurrent endometrial cancer: a single institution experience.
Yunokawa M, Abe A, Wang X, Toyohara Y, Nimura R, Komoto T, Misaka S, Yoshimitsu T, Ikki A, Kamata M, Nishino S, Kanno M, Fusegi A, Netsu S, Aoki Y, Omi M, Tanigawa T, Okamoto S, Nomura H, Kanao H. Yunokawa M, et al. Among authors: omi m. Int J Clin Oncol. 2025 Feb;30(2):371-379. doi: 10.1007/s10147-024-02667-0. Epub 2024 Dec 6. Int J Clin Oncol. 2025. PMID: 39641902
135 results